Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Abstracts : 31st European Congress of Pathology.
Nataras BR, Dema A, Lazureanu CD, Herman D, Taban S, Cornianu M, Szilagyi D, Muresan A, Costi S, Uglai I, Suciu SC, Anderco D, Iacob M. Nataras BR, et al. Among authors: suciu sc. Virchows Arch. 2020 Feb;476(2):329. doi: 10.1007/s00428-019-02690-x. Virchows Arch. 2020. PMID: 31691848 Free PMC article.
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.
Musoro J, Sleurs C, Rowsell A, Suciu S, Kicinski M, Chantziara S, Coens C, Pe M, Missotten P, Vandecruys E, Uyttebroeck A, Dresse MF, Pluchart C, Ferster A, Freycon C, Van Der Werff Ten Bosch J, Rohrlich P, Benoit Y, Piette C, Darlington AS; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLG) and Children's Leukemia Group (CLG). Musoro J, et al. Among authors: suciu s. Pediatr Blood Cancer. 2025 Feb;72(2):e31446. doi: 10.1002/pbc.31446. Epub 2024 Nov 30. Pediatr Blood Cancer. 2025. PMID: 39616416 Free article.
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia.
Domenech C, Kicinski M, De Moerloose B, Piette C, Chahla WA, Kornreich L, Pasquet M, Uyttebroeck A, Theron A, Poirée M, Arfeuille C, Bakkus M, Grardel N, Paillard C, Freycon C, Millot F, Simon P, Philippet P, Pluchart C, Suciu S, Rohrlich P, Ferster A, Bertrand Y, Cavé H; Children's Leukemia Group (CLG) of the European Organization for Research and Treatment of Cancer (EORTC). Domenech C, et al. Among authors: suciu s. Hemasphere. 2024 Nov 13;8(11):e70025. doi: 10.1002/hem3.70025. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39540141 Free PMC article.
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.
Eggermont AM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Boers-Sonderen M, Di Giacomo AM, van den Eertwegh AJ, Grob JJ, Gutzmer R, Jamal R, van Akkooi ACJ, Lorigan P, Grebennik D, Kreplere C, Marreaud S, Suciu S, Robert C. Eggermont AM, et al. Among authors: suciu s. Eur J Cancer. 2024 Nov;211:114327. doi: 10.1016/j.ejca.2024.114327. Epub 2024 Sep 12. Eur J Cancer. 2024. PMID: 39288737 Clinical Trial.
Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial.
Efficace F, Kicinski M, Coens C, Suciu S, van der Velden WJFM, Noppeney R, Chantepie S, Griskevicius L, Neubauer A, Audisio E, Luppi M, Fuhrmann S, Foà R, Crysandt M, Gaidano G, Vrhovac R, Venditti A, Posthuma EFM, Candoni A, Baron F, Legrand O, Mengarelli A, Fazi P, Vignetti M, Giraut A, Wijermans PW, Huls G, Lübbert M. Efficace F, et al. Among authors: suciu s. Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625. Blood. 2024. PMID: 38717861 Free article. Clinical Trial.
317 results